Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/26/2012CN102688475A Anti-cancer extractive of wall gecko
09/26/2012CN102688192A Sustained-release preparation of polypeptide drug for treating diabetes and production method thereof
09/26/2012CN102688181A Preparation method of medical squid-skin collagen oligopeptide gel
09/26/2012CN102180951B Cholesterol modified anti-human immunodeficiency virus (HIV) polypeptide medicament and application thereof
09/26/2012CN102145178B PEG interleukin 15
09/26/2012CN102144968B Oral suspension of liposome-encapsulated insulin lyophilized preparation and preparation process thereof
09/26/2012CN102121020B Gene complete sequence of siganus oramin L-amino acid oxidase and application thereof
09/26/2012CN102091043B Growth factor slow release microballoon and preparation method thereof
09/26/2012CN102088985B Intestinal environment-improving agent
09/26/2012CN101991601B Method for preparing uroacitide composition
09/26/2012CN101974089B Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection
09/26/2012CN101926979B Use of fungal immunomodulatory protein
09/26/2012CN101879305B Application of serum thymic factors to preparation of anti-tumor medicine and protection medicine of tumor physical and chemical treatment medicine
09/26/2012CN101875700B Method for improving bioactivity of exendin fusion protein
09/26/2012CN101835483B Treatment of atherosclerosis
09/26/2012CN101804193B CTLA4lg and derivatives thereof used for resisting viruses
09/26/2012CN101747437B Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein
09/26/2012CN101494970B Oral formulation for enteric disorders and/or rehydration
09/26/2012CN101460067B Induction of tolerance to egg proteins
09/26/2012CN101282763B Milk derived composition and use to enhance muscle mass or muscle strength
09/26/2012CN101119743B Immunopotentiating agent
09/26/2012CN101086007B Manyzoned polypore glycopeptide production method and formulation thereof
09/26/2012CN101076347B Devices and methods for integrated continuous manufacturing of biological molecules
09/25/2012USRE43691 C1 inhibitor with short half-life transient treatment
09/25/2012US8273870 Compositions and methods for inhibiting expression of a mutant gene
09/25/2012US8273868 Compositions and methods for inhibiting viral replication
09/25/2012US8273855 Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system
09/25/2012US8273854 GLP-1 analog fusion proteins
09/25/2012US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/25/2012US8273724 Melanoma antigens and their use in diagnostic and therapeutic methods
09/25/2012US8273716 Use of LHRH antagonists for intermittent treatments
09/25/2012US8273715 Methods of treating fragile X syndrome
09/25/2012US8273714 ADAMTS13 genes and proteins and variants, and therapeutic compositions and methods of utilizing the same
09/25/2012US8273713 Dietetics, eating disorders, antidiabetic agents
09/25/2012US8273712 Promoting wound healing by administering a prostaglandin E and granulocyte-macrophage colony stimulating factor
09/25/2012US8273711 Topical drug delivery using phosphatidylcholine
09/25/2012US8273710 Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
09/25/2012US8273709 Triazole-containing macrocyclic HCV serine protease inhibitors
09/25/2012US8273708 Regulation of paracellular permeability of the ocular surface epithelium, corresponding to the anterior segment of the eye; modulating the opening of tight junctions of the ocular epithelium; keratitis, conjunctivitis and dry eye syndrome
09/25/2012US8273706 Isobarically labeled analytes and fragment ions derived therefrom
09/25/2012US8273705 Conversion of apoptotic proteins
09/25/2012US8273704 Use of repeat sequence protein polymers in personal care compositions
09/25/2012US8273703 Nucleotide sequences coding immunoglobulin/ligand fusion for use in targeting and treating bone and inflammatory disorders
09/25/2012US8273568 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
09/25/2012US8273552 Modified growth hormone polypeptides
09/25/2012US8273548 Nucleic acids encoding a human PAP1 polypeptide
09/25/2012US8273383 Methods and compositions for treatment of preeclampsia
09/25/2012US8273372 Extracellular matrix composition
09/25/2012US8273369 Reinforced absorbable synthetic matrix for hemostatic applications
09/25/2012US8273360 Neisseria membrane protein mixture for use in developing vaccine to prevent bacterial infection; bactericides; immunotherapy
09/25/2012US8273358 Activatable clostridial toxins
09/25/2012US8273353 Inhibitors of vascular endothelial growth factor activity
09/25/2012US8273348 Lipase variants for pharmaceutical use
09/25/2012US8273347 Autologous treatment of degenerated disc with cells
09/25/2012US8273343 Protein-polymer conjugates
09/25/2012US8273342 Anti-virus therapy for respiratory diseases
09/25/2012US8273341 Antiviral compounds
09/25/2012CA2648109C Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine
09/25/2012CA2558985C Erythropoietin liquid formulation
09/25/2012CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
09/25/2012CA2482598C Peptide inhibitors of protein kinase c
09/25/2012CA2466591C Template-fixed peptidomimetics as inhibitors of serine proteases
09/25/2012CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression
09/25/2012CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
09/25/2012CA2389337C Reversibly inactivated acidified plasmin
09/25/2012CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses
09/20/2012WO2012126013A2 Method for making pluripotent stem cells
09/20/2012WO2012125998A1 Yeast-brachyury immunotherapeutic compositions
09/20/2012WO2012125948A1 Compositions and methods for producing clostridial collagenases
09/20/2012WO2012125942A1 Combination therapy with leukotoxin
09/20/2012WO2012125914A1 Injectable delivery system for heparan sulfate binding growth factors
09/20/2012WO2012125872A2 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
09/20/2012WO2012125830A2 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012WO2012125828A2 Methods of treating breast cancer with anthracycline therapy
09/20/2012WO2012125809A1 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
09/20/2012WO2012125808A1 Multiplexed detection with isotope-coded reporters
09/20/2012WO2012125720A2 Polypeptides having immunoactivating activity and methods of producing the same
09/20/2012WO2012125487A1 Compositions, methods and uses for radioprotectants
09/20/2012WO2012125471A1 Methods and compositions relating to mesenchymal stem cell exosomes
09/20/2012WO2012125408A1 Pegylated apelin and uses thereof
09/20/2012WO2012125405A2 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
09/20/2012WO2012124998A2 Bio-pin
09/20/2012WO2012124641A1 Activity enhancer for anticancer agent
09/20/2012WO2012123959A2 Copolymer-1, process for preparation and analytical methods thereof
09/20/2012WO2012123957A1 Oligopeptides and process for preparation thereof
09/20/2012WO2012123519A2 Human insulin analogues and derivatives comprising cysteine substitutions
09/20/2012WO2012123381A1 Use of low dose il-2 for treating autoimmune - related or inflammatory disorders
09/20/2012WO2012122985A1 Antagonists of the interleukin- 1 receptor
09/20/2012WO2012122943A1 Anti-hepatitis b virus x protein polypeptide drug
09/20/2012WO2012122942A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122941A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122930A1 Lhrh antagonist derivative, and preparation method and applications thereof
09/20/2012WO2012122860A1 Human insulin and analog conjugate thereof
09/20/2012WO2012122859A1 Human keratinocyte growth factor-1 disulfide variant, preparation method thereof, and application thereof
09/20/2012WO2012122642A1 Uses of modified elr-cxc chemokine g31p to treat cancer
09/20/2012WO2012122640A1 Compositions, diagnostic methods using epithelial extracellular matrix proteins
09/20/2012WO2012106427A3 Methods for treating diabetic foot ulcers
09/20/2012WO2012106264A3 Treatment and prevention of bacterial vaginosis and gardnerella vaginalis infections
09/20/2012WO2012099447A3 Transgenic pig expressing stnfr1-fc genes and the use thereof
09/20/2012WO2012098546A8 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 3163